First Generic Esmolol Hydrochloride Product Launched for Tachycardia – Drug for nerve pain boosts high for opioid abusers. (866) 348-2889
Mylan has launched the first generic version of esmolol hydrochloride (Brevibloc, Baxter) in the United States for treatment of tachycardia.1 According to Mylan, Esmolol Hydrochloride in Sodium Chloride Injection, 2,500 mg/250 mL (10 mg/mL) Single-Dose Plastic Bag, and 2,000 mg/100 mL (20 mg/mL) Single-Dose Plastic Bag products are being offered to the global pharmaceutical company’s institutional customers.
Mylan’s esmolol hydrochloride products are in the market following FDA approval of an Abbreviated New Drug Application (ANDA). Esmolol Hydrochloride in Sodium Chloride Injection is indicated for the short-term treatment of control of ventricular rate in supraventricular tachycardia, including atrial fibrillation and atrial flutter, and control of heart rate in noncompensatory sinus tachycardia, and control of perioperative tachycardia and hypertension.